Joslin Clinic brings to the joint venture expertise in caring for and educating people with diabetes and their families, as well as proven disease management techniques for identifying patients at risk for developing medical complications and preventing those complications.
BIDMC offers an extensive pool of physician specialists who have expertise in treating the complications of diabetes (i.e. heart disease, kidney and pancreas dysfunction, obesity, neuropathy, vascular complications and high-risk pregnancy).
The agreement expands the longstanding collaboration between the two nonprofit institutions, which are both affiliated with Harvard Medical School. In addition to strengthening current diabetes treatment and education programs, Joslin and BIDMC will create new clinical guidelines and interactive programs in a number of areas including diabetes and cardiovascular disease; eye care for those with diabetes; kidney and pancreas transplantation as well as clinical trials of islet cell transplantation; high-risk pregnancy; and obesity, a major risk factor for the development of type 2 diabetes.
Joslin and BIDMC will continue existing programs in vascular surgery for diabetes complications; clinical endocrinology; nephrology; mental health; podiatry services; and patient education and training. New emphasis will be placed on joint programs for training specialists in the area of diabetes and endocrinology.
"We will take both the care of people with diabetes and the relationship between the two institutions to a new level," said Alan Moses, M.D., Chief Medical Officer, Joslin Clinic. "By combining our expertise, we are not only able to provide preeminent, m
Contact: Jerry Berger
Beth Israel Deaconess Medical Center